slide 1

Back to the List of the Granted Patents                                                Click here to download AP2001 PDF

(11)    Patent No :    AP 2001   
(21)    Application No :    AP/P/2003/002847   
(22)    Filing Date :    17.01.2002   
(24)    Date of Grant &    11.05.2009   
           
(45)    Publication :

(30)  Priority Data       
(33) Country    (31) Number    (32) Date
IN    50/MUM/2001    17.01.2001

(84)    Designated State

GM    GH    KE    LS   MW  MZ   SL   SD   SZ
T Z    UG    ZM    ZW

(73) Applicant(s)

KHAMAR Bakulesh Mafatlal, 201 Ashadha, Vassundhara

Colony, Gulbai Tekra, Ahmedabad 380 006, Gujarat,
India

(72) Inventors

KHAMAR Bakulesh Mafatlal, India

(74) Representative

GALLOWAY & COMPANY
 

(51)  International  Classification   A61K 35/74 (2006.01)    A61P 31/18 (2006.01)
A61P 37/02 (2006.01)   


(54)    Title

Immunomodulator for the management of human immunodeficiency  virus (HIV) disease/infection.

(57)    Abstract

Human Immunodeficiency virus causes depletion of CD4 cells. The depletion of CD4 cells results in decrease in immunity of an infected individual. Due to decrease immunity various opportunistic infections occur. These infections are

cause for morbidity and mortality in HIV infected individuals. The treatment of

HIV includes antiretroviral drugs. These drugs have their own side effects and immune reconstitution achieved is delayed and slow. Various attempts have been made to improve CD4 count, use of IL-2 is one of them. It is associated with systemic side effects during the period of its administration. The present invention provides immunomodulator based on Mycobaclerium w.

Its use in associated with symptomatic improvement as well as


(56)    Documents Cited :    REDDI P.P. et al; Int. J. of Leprosy & Other Mycobacterial Diseases   WO 94 06466 A   GB 2

236 480 A   GULERIA I et al; Medical Microbiology and immunology Germany, Jul 1993.

Newsletter

Join our newsletter for CIPIT news through subscriptions!

SEND

Social Media

 

    

Contact Us

TEL : (254) 703 034 612